Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer
CTR20170835Phase 3Completed
- Sponsor
- Zai Lab
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niraparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Zai Lab. Started Sep 2017; status: completed.
02
Drugs
niraparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on CTR20170835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170835.